Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes

Podiatry Arena Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

9th April 2009, 05:10 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 3,060

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 5 Times in 5 Posts

Update On FDA Advisory Committee Meeting On Liraglutide For The Treatment Of Type 2 Diabetes

Podiatry Arena members do not see these ads

Novo Nordisk announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has finalised its discussions of questions related to liraglutide, a once-daily human GLP-1 analogue. The Advisory Committee voted on questions related to the risk profile of liraglutide.

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Surveyed Experts Indicate That Byetta LAR And Victoza Have Advantages Over Actos In The Treatment Of Type 2 Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	25th March 2009 06:10 AM
Newly Phase 3 Data Confirm Liraglutide Lowers Blood Sugar And Weight In Type 2 Diabetes Patients	RSSFeedBot	Latest Diabetes Medicine Research & News	0	8th February 2009 05:21 AM
New paradigm proposed for treatment of type 2 diabetes	NewsBot	Diabetic Foot & Wound Management	1	24th July 2008 03:29 PM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 12:18 PM.

User Name		Remember Me?
Password